Delivering future health solutions.
Health & Life Sciences
Liverpool’s global leadership in health and life sciences is driving innovation in specialist areas such as: Infection; Precision Medicine; Children’s Health; Veterinary Science; Independent Living; and Big Data, Sensors and Internet of Things.
At the heart of our life sciences cluster is the Liverpool Knowledge Quarter, which is home to the University of Liverpool, Liverpool John Moores University, Liverpool School of Tropical Medicine and the Royal Liverpool University Hospital. The area is fast becoming one of the world’s leading innovation districts and upon completion of its new hospitals, will be one of the largest academic and clinical campuses in the UK.
-
Major European Biomanufacturing cluster -
Highest number of specialist hospitals outside of London -
Home to the world renowned Liverpool School of Tropical Medicine
-
The highest concentration of Category Level 3 laboratories in the UK
There is no better validation of Liverpool’s medical credentials than the global players that choose to locate and reinvest here. From stem cell and gene therapy treatments and nutraceuticals research and development, to large scale manufacturing and the production of pharmaceuticals, vaccines and biologics.
Liverpool is home to companies delivering world-class solutions in life sciences from research and trials to medical manufacturing. Significant new investments in modern production facilities at these companies have created a vibrant, efficient and cost-competitive environment to produce new drugs and vaccines.
-
The North West is the UK’s third largest life sciences sector by employee numbers -
World class research centres of excellence and facilities -
Life sciences worth in excess of £1.7 billion per annum
The emergence of sensor technologies, big data and robotics is changing the possibilities and processes in the life sciences sector. Liverpool is leading the way with its LCR 4.0 programme, creating a new infrastructure that connects physical and digital assets to make the industrial internet a reality.
Latest Health & Life Sciences news
-
Robotic labs, fighting infections and skills training among first seven Innovation Zone projects set for approval
Building robotic labs and expanding Sci-Tech Daresbury are among the first seven Liverpool City Region Innovation Zone projects set for approval.
-
From Littlewoods to Life Sciences: How crucial development is enabling Liverpool City Region’s key growth sectors to thrive
A city long celebrated for its maritime heritage and musical legacy, Liverpool, in recent years, has been building a new reputation as a centre for creative, digital, and knowledge-led innovation.
-
Liverpool City Region Unveils Ambitious Investment Zone Plans at MIPIM Cannes 2024
Liverpool’s ambitious investment plans for the future took center stage at MIPIM Cannes 2024, as new details emerged regarding the Liverpool City Region Investment Zone. Designed to inject vitality into the local economy, the Zone aims to generate 8,000 job opportunities while acting as a catalyst for innovation and growth.
-
Chancellor Confirms AstraZeneca’s £450 million Liverpool Expansion
Chancellor Jeremy Hunt has today (6th March 2024)announced a significant investment move by pharmaceutical giant AstraZeneca during his Budget speech. AstraZeneca is set to inject £450 million into the establishment of a new vaccine manufacturing plant in Liverpool, expanding its existing presence in the city.
-
University of Liverpool to co- lead UK’s flagship £12M AI for Chemistry Hub
University of Liverpool to co- lead UK’s flagship £12M AI for Chemistry Hub
-
Global IP firm marks its first anniversary at Sciontec AI
Marks & Clerk reflects on its first year at Sciontec AI and sets out its Liverpool City Region focused plans for 2024.
-
Sciontec attracts strong influx of customers for 2024
Sciontec Developments Limited (Sciontec) has started the year on a high, welcoming 12 new customers to its innovation centres in Liverpool city centre.